Application of four pricing models for orphan medicines: a case study for lumasiran

Application of four pricing models for orphan medicines: a case study for lumasiran

Abstract Background The combination of high prices and uncertain effectiveness is a growing challenge in the field of orphan medicines, hampering health technology assessments. Hence, new methods for establishing price benchmarks might be necessary to support reimbursement negotiations. In this stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Noa Rosenberg, Evert Manders, Sibren van den Berg, Lisa J. Deesker, Sander F. Garrelfs, Saco J. de Visser, Jaap W. Groothoff, Carla E. M. Hollak
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Pricing models
Lumasiran
Orphan medicinal products
Primary hyperoxaluria type 1
Online Access:https://doi.org/10.1186/s13023-024-03446-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13023-024-03446-w

Similar Items